• G007-LK Tankyrase 1/2 Inhibitor: Translational Leverage in A

  2026-05-13

  This thought-leadership article examines the mechanistic underpinnings and translational promise of G007-LK, a selective tankyrase 1/2 inhibitor, for researchers working on APC-mutation-driven colorectal cancer and hepatocellular carcinoma. Integrating recent mechanistic evidence with strategic protocol guidance, it contextualizes G007-LK’s workflow impact, differentiates its role in the competitive landscape, and projects actionable insights for pioneering precision oncology.

• Redefining AMPK’s Role in Autophagy: Implications for Vps34

  2026-05-13

  This study challenges the prevailing model of AMPK as a positive autophagy regulator, demonstrating that AMPK suppresses ULK1-mediated autophagy initiation during energy stress. These findings reshape the mechanistic understanding of autophagy regulation and offer new perspectives for the design of autophagy inhibition assays.

• SIRT4 Regulation of Glutamine Metabolism Mitigates Liver Fib

  2026-05-12

  This study uncovers how SIRT4 suppresses glutamine metabolism in hepatic stellate cells (HSCs), thereby reducing their activation and proliferation—a central driver of liver fibrosis progression. The findings elucidate novel metabolic control points, suggesting targeted interventions for chronic liver disease.

• Amikacin (BAY416651): Optimizing Antibiotic Resistance Resea

  2026-05-12

  Amikacin (BAY416651) stands out as a powerful tool for dissecting bacterial protein synthesis inhibition and multidrug resistance mechanisms. Its robust stability and enzyme resistance profile empower researchers to probe challenging infections and novel delivery strategies, as exemplified by targeted dendritic cell-based methods.

• PNN Loss in Hippocampal CA2 Drives Social Memory Deficits in

  2026-05-11

  This study reveals that degradation of perineuronal nets (PNNs) in the hippocampal CA2 region is a direct mechanism underlying social cognition memory loss in Alzheimer’s disease (AD) mouse models. By linking matrix metalloproteinase (MMP)-mediated PNN disruption to cognitive deficits and demonstrating that chronic MMP inhibition preserves social memory, the research identifies PNN integrity as a promising therapeutic target for AD.

• Trichostatin A Potentiates Chemotherapy in Pancreatic Cancer

  2026-05-11

  This study introduces a rapid in vivo screening platform leveraging Rgs16::GFP to identify effective chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA). Notably, the histone deacetylase inhibitor Trichostatin A (TSA) was found to enhance the efficacy of gemcitabine and JQ1, providing a mechanistically informed approach to overcoming resistance in aggressive PDA.

• Cardiogreen (Indocyanine Green): Precision in Diagnostics an

  2026-05-10

  Explore how Cardiogreen (Indocyanine Green) advances both vascular diagnostics and photodynamic therapy through molecular precision. This article uniquely bridges mechanistic insights with practical protocols, providing researchers with new perspectives on optimizing cardiac output measurement and apoptosis induction.

• Sildenafil Citrate: cGMP-PDE5 Inhibitor for Vascular Assays

  2026-05-09

  Sildenafil Citrate from APExBIO delivers precise, reproducible inhibition of cGMP-specific phosphodiesterase type 5, empowering advanced research into vascular smooth muscle relaxation and proteoform-specific signaling. This guide translates the newest proteomics breakthroughs into actionable protocols and troubleshooting strategies for robust, next-generation workflows.

• Moxidectin Enhances Polyene Efficacy Against Oral Candidiasi

  2026-05-08

  This article reviews a 2024 study demonstrating that moxidectin increases ergosterol synthesis in Candida albicans, thereby synergizing with polyene antifungals such as Amphotericin B to improve antifungal efficacy, especially in oral candidiasis models. The research offers mechanistic insights with direct translational implications for fungal infection research and addresses emerging challenges of resistance and polyene toxicity.

• Demethyleneberberine: Protocol-Driven Innovation for Cell Mo

  2026-05-08

  Demethyleneberberine (DMB) stands out as a versatile anti-inflammatory and neuroprotective agent with workflow-ready protocols for cell culture, disease modeling, and translational research. This article translates pivotal mechanistic breakthroughs and troubleshooting insights into actionable steps for reliable, high-impact experiments.

• Metoprolol Tartrate: Applied Protocols in Cardiovascular Res

  2026-05-07

  Metoprolol Tartrate stands out as a selective β1-adrenergic blocking agent, enabling reproducible, mechanistically clear cardiovascular and hematopoietic research. This guide delivers actionable workflows, troubleshooting, and protocol enhancements, leveraging the compound’s selectivity and stability for high-impact studies.

• SMYD2 Inhibition Attenuates Cisplatin-Induced Renal Fibrosis

  2026-05-07

  This study demonstrates that pharmacological inhibition of SMYD2 using AZ505 or LLY507 protects against cisplatin-induced renal fibrosis and inflammation in a chronic kidney disease (CKD) mouse model. The findings identify SMYD2 as a critical regulator of renal fibrosis through epigenetic and inflammatory pathways, informing future epigenetic regulation research and potential therapeutic strategies.

• Patient-Derived Gastric Cancer Assembloids Reveal Drug Resis

  2026-05-06

  This study introduces a gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, better capturing the tumor microenvironment and heterogeneity. The model enables more physiologically relevant drug screening, revealing how stromal components modulate gene expression and therapeutic resistance, with significant implications for cancer biology research and personalized therapy development.

• A-769662: Redefining AMPK Activation and Autophagy Control

  2026-05-06

  Explore how the potent AMPK activator A-769662 is reshaping our understanding of cellular energy stress and autophagy regulation. This in-depth analysis goes beyond metabolic research to reveal new mechanistic insights with direct impact on experimental design.

• Clathrin-Mediated Endocytosis Drives Grass Carp Reovirus Ent

  2026-05-05

  Wang et al. (2018) systematically dissected the entry mechanisms of type III grass carp reovirus (GCRV104) into host cells, revealing a critical reliance on clathrin-mediated endocytosis and endosomal acidification. Their inhibitor analysis clarifies the mechanistic boundaries distinguishing clathrin-dependent viral entry from alternative endocytic and ion channel pathways, informing future antiviral research strategies.

16122 records 1/1075 page Next 12345 下5页 Last page